HB 1968·TN·house
Opioids - As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.
Signed into LawFiled Jan 22, 2026
Sponsor: Andrew Farmer (R)
Latest Action
Comp. became Pub. Ch. 888
May 18, 2026
Summary
The bill amends state statutes to add three drug manufacturers—Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc.—to the group of companies the attorney general may pursue for opioid-related claims. It updates the language in Title 20 and Title 33 to reflect this expanded list. The change enables Tennessee to seek settlements or judgments from these additional firms.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when HB 1968 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 1968 freeOr ask your AI assistant about HB 1968 directly:
Add to Claude, ChatGPT or Cursor